Experimental drug entinostat studied for rare abdominal cancer, trial halted early
Disease control
Terminated
This study tested a drug called entinostat in people with advanced abdominal neuroendocrine tumors that had come back or stopped responding to other treatments. Only 5 people enrolled before the trial was stopped early. The goal was to see if the drug could shrink tumors or slow …
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC